Company News: Page (1) of 1 - 05/28/14 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

  (May 28, 2014)

NEW YORK, May 28, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

http://www.reportlinker.com/p02133166/North-America-Cardiovascular-Monitoring-and-Diagnostic-Devices-Market-Outlook-to-2020.html

North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

Summary

GlobalData's new report, "North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the North America Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.


Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiovascular Monitoring and Diagnostic Devices categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the North America Cardiovascular Monitoring and Diagnostic Devices market.
- Key players covered include GE Healthcare, Philips Healthcare, Welch Allyn Inc., OSI Systems, Inc., CareFusion Corporation, Cardiac Science Corporation, Schiller AG and Card Guard Scientific Survival, Ltd.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Cardiovascular Monitoring and Diagnostic Devices Market, North America 13
3.1 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), 2005-2020 13

3.2 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Category Comparison by Revenue ($m), 2005-2020 15
3.3 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), 2005-2012 17
3.4 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), 2012-2020 19
3.5 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2020 21
3.6 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2012 23
3.7 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2012-2020 25
3.8 Cardiovascular Monitoring and Diagnostic Devices Market, North America, Company Share by Revenue ($m), 2011-2012 27
4 Cardiovascular Monitoring and Diagnostic Devices Market, Canada 29
4.1 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), 2005-2012 29
4.2 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), 2012-2020 31
4.3 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), 2005-2012 33
4.4 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), 2012-2020 35
4.5 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Average Price ($), 2005-2020 37
4.6 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Distribution Share by Revenue ($m), 2011-2012 39
4.7 Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 40
5 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico 42

5.1 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), 2005-2012 42
5.2 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), 2012-2020 44
5.3 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), 2005-2012 46
5.4 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), 2012-2020 48
5.5 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Average Price ($), 2005-2020 50
5.6 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Distribution Share by Revenue ($m), 2011-2012 52
5.7 Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Company Share by Revenue ($m), 2011-2012 53
6 Cardiovascular Monitoring and Diagnostic Devices Market, United States 55
6.1 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2005-2012 55

6.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2012-2020 57
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2005-2012 59
6.4 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2012-2020 61
6.5 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), 2005-2020 63
6.6 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 65
6.7 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2011-2012 66
7 Overview of Key Companies in North America Cardiovascular Monitoring and Diagnostic Devices Market 68
7.1 GE Healthcare 68
7.1.1 Company Overview 68
7.2 Philips Healthcare 68
7.2.1 Company Overview 68
7.3 CareFusion Corporation 68
7.3.1 Company Overview 68
7.4 Welch Allyn Inc. 69

7.4.1 Company Overview 69
7.5 OSI Systems, Inc. 69
7.5.1 Company Overview 69
7.6 Opto Circuits India Limited 69
7.6.1 Company Overview 69
7.7 Schiller AG 70
7.7.1 Company Overview 70
7.8 Mortara Instrument, Inc. 70
7.8.1 Company Overview 70
7.9 Nihon Kohden Corporation 70
7.9.1 Company Overview 70
7.10 Fukuda Denshi Co., Ltd. 71
7.10.1 Company Overview 71
8 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 72
9 Recent Developments 76
9.1 Corporate Communications 76
9.1.1 Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director 76
9.1.2 Feb 12, 2014: ICU Medical Names Vivek Jain as New Chief Executive Officer and Chairman 76
9.1.3 Jan 31, 2014: AMAG Pharmaceuticals Announces Issuance of New U.S. Patent for Ferumoxytol 77
9.1.4 Dec 19, 2013: Bioheart Reports Update on CEO 77

9.1.5 Nov 22, 2013: Voyage Care Acquires Ingleby Care 77
9.1.6 Nov 18, 2013: Bioheart's President/CEO Mike Tomas Named Chair of the eMerge Innovate Advisory Board of eMerge Americas 78
9.1.7 Oct 21, 2013: ICU Medical Announces Management Transition 79
9.1.8 Sep 23, 2013: Bioheart Boosts Team with Regulatory, Finance and Administrative Expertise Three New Key Positions Added 80
9.1.9 Sep 19, 2013: Atherotech Diagnostics Lab Bolsters Research Efforts with Addition of Abate as Chief Clinical Officer 80
9.1.10 Sep 19, 2013: IMRIS Announces Addition of Dr. Vipul Patel to SYMBIS Advisory Board 81
9.1.11 Sep 13, 2013: Arrhythmia Research Technology Announces Resignation of CFO and Appointment of New Principal Financial Officer 81
9.1.12 Aug 28, 2013: Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc. 82
9.1.13 Aug 15, 2013: R. Stephen Armstrong Joins IMRIS Board of Directors 82
9.1.14 Aug 01, 2013: CardioNet Holding Company Structure Effective 83
9.1.15 Jul 29, 2013: Jay D. Miller Appointed Chief Executive Officer 83
9.1.16 Jul 23, 2013: Vincent Caponi Joins Welch Allyn Board of Directors 84
9.1.17 Jun 04, 2013: Cheetah Medical Appoints Chris Hutchison As CEO 84
9.2 Financial Announcements 85
9.2.1 May 06, 2014: ICU Medical Announces First Quarter 2014 Results 85

9.2.2 Apr 16, 2014: Osteoarthritis Study shows ActiPatch Therapy Significantly Relieves Knee Pain 85
9.2.3 Mar 27, 2014: Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2013 88
9.2.4 Mar 04, 2014: IMRIS Reports Fourth Quarter and Annual 2011 Financial Results 89
9.2.5 Feb 12, 2014: ICU Medical Announces Fourth Quarter and Fiscal Year 2013 Results 91
9.2.6 Jan 20, 2014: Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association's Journal, Circulation 92
9.2.7 Nov 19, 2013: Arrhythmia Research Technology Announces Third Quarter 2013 Results 93
9.2.8 Nov 14, 2013: Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013 94
9.2.9 Nov 05, 2013: Vasomedical to Report Third Quarter 2013 Results on November 14, 2013 95
9.2.10 Nov 05, 2013: BioTelemetry Reports Third Quarter 2013 Financial Results 96
9.2.11 Nov 04, 2013: IMRIS Reports Third Quarter 2013 Financial Results 97
9.2.12 Oct 29, 2013: BioTelemetry to Release Third Quarter 2013 Earnings Results on November 5, 2013 99
9.2.13 Oct 21, 2013: ICU Medical Reports Third Quarter 2013 Results 99
9.2.14 Oct 16, 2013: ICU Medical Announces Time of Third Quarter 2013 Earnings Call 100
9.2.15 Oct 08, 2013: Arrhythmia Research Technology Announces Second Quarter 2013 Results 100
9.2.16 Oct 02, 2013: Arrhythmia Research Technology Announces Updated Preliminary Second Quarter Results 102
9.2.17 Aug 20, 2013: First Databank Acquires Design Clinicals, Medication Reconciliation Solutions Provider 102
9.2.18 Aug 20, 2013: Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Second Quarter Results 104
9.2.19 Aug 13, 2013: IMRIS reports second quarter 2013 financial results 105

9.2.20 Aug 13, 2013: Vasomedical Announces Financial Results for the Second Quarter of 2013 107
9.2.21 Aug 06, 2013: Vasomedical to Report Second Quarter 2013 Results on August 13, 2013 108
9.2.22 Jul 30, 2013: CardioNet Reports Second Quarter 2013 Financial Results 108
9.2.23 Jul 23, 2013: CardioNet to Release Second Quarter 2013 Earnings Results on July 30, 2013 110
9.2.24 Jul 18, 2013: ICU Medical Reports Second Quarter 2013 Results 110
9.2.25 Jun 28, 2013: Arrhythmia Research Technology, Inc. Announces First Quarter 2013 Results 111
9.2.26 Jun 17, 2013: Takeda Announces Availability Of Nesina In US Pharmacies 112
9.2.27 Jun 03, 2013: Arrhythmia Reports Revenue Of $20.6m In 2012 113
9.2.28 May 15, 2013: Vasomedical Reports Revenue Of $7.3m In Q1 2013 114
9.2.29 May 09, 2013: Bioheart Reports Q1 2013 Results 114
9.3 Government and Public Interest 116
9.3.1 Jan 06, 2014: ICU Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference 116
9.3.2 Jan 02, 2014: Topera to Present at the 32nd Annual J.P. Morgan Healthcare Conference 116
9.3.3 Dec 31, 2013: Bioheart to Present at Vail Symposium's Winter Program on Cell Therapy 116
9.3.4 Dec 02, 2013: ZOLL Summit 2014 Call for Presentations 116
9.3.5 Nov 25, 2013: Topera to Present at the 25th Annual Piper Jaffray Health Conference 116
9.3.6 Nov 21, 2013: ICU Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference 117
9.3.7 Nov 13, 2013: IMRIS to present at Investor Healthcare Conferences in New York 117
9.3.8 Oct 23, 2013: Additional dedicated trainer hospital established in the USA 117
9.3.9 Aug 09, 2013: IMRIS CEO Jay D. Miller to present at Canaccord Genuity 33rd Annual Global Growth Conference 118
9.4 Legal And Regulatory 118

9.4.1 Apr 17, 2014: Boston Heart Granted New York Laboratory Permit for Diagnostic Testing 118
9.5 Other Significant Developments 119
9.5.1 Feb 24, 2014: AliveCor Offers Integration With Practice Fusion's Electronic Health Records Platform 119
9.5.2 Feb 20, 2014: Boston Heart Diagnostics Awarded $1.0 Million in Tax Incentives from the Massachusetts Life Sciences Center 119
9.5.3 Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with O&D Biotech 120
9.5.4 Dec 04, 2013: BioTelemetry, Inc. Announces Reduction to Medicare Reimbursement for Remote Cardiac Monitoring Services 120
9.5.5 Dec 02, 2013: Bioheart Announces Agreement With StemMD to Provide Bioheart Therapies to Its Network 121
9.5.6 Nov 18, 2013: AliveCor transforms Heart Monitor into eHealth Service 121
9.5.7 Nov 15, 2013: Millar Appointed Exclusive US Distributor of CD Leycom INCA Pressure-Volume Loop System 122
9.5.8 Oct 25, 2013: Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East 122
9.5.9 Oct 16, 2013: Bioheart Announces Contract With African-Middle East Medical to Begin Distributing Stem Cell Products in Uganda 123
9.5.10 Oct 09, 2013: $2 Million Awarded to Sutter Health, IBM and Geisinger Health System to Study Heart Failure Prediction 123
9.5.11 Aug 23, 2013: Arrhythmia Research Technology Receives NYSE MKT LLC Exchange Compliance Notice 124
9.5.12 Jul 09, 2013: Behrman Capital Portfolio Company Atherotech Completes Recapitalization 125
9.6 Product News 125

9.6.1 Apr 16, 2014: AtCor Medical Receives Patent in USA 125
9.6.2 Mar 27, 2014: First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries 125
9.6.3 Mar 17, 2014: Vasomedical Announces Biox's MobiCare Wireless Patient Monitors Receives Marketing Approval in China 126
9.6.4 Feb 13, 2014: New Data Support Use of iRhythm's ZIO Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients 127
9.6.5 Jan 22, 2014: UCLA researchers develop risk calculator to predict survival in heart failure patients 128
9.6.6 Jan 06, 2014: FDA Reclassifies ECP Devices for Refractory Angina as Class II 129
9.6.7 Jan 02, 2014: ZIO Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine 130
9.6.8 Nov 25, 2013: Independent Multi-Center Clinical Study Shows the Use of Topera's 3D Mapping System Improved Long-Term Outcomes for Atrial Fibrillation Patients 131
9.6.9 Nov 18, 2013: AliveCor Transforms Heart Monitor into eHealth Service 132
9.6.10 Oct 10, 2013: CardioComm Solutions' HeartCheck Technologies to be used in Canadian Clinical Arrhythmia Risk Screening and Stoke Prevention Trial 133
9.6.11 Oct 07, 2013: MDxHealth's Prostate Cancer Test Meets Endpoints In DOCUMENT Trial 134
9.6.12 Aug 23, 2013: AliveCor Launches New Feature to Enhance Visual Quality of ECG 135
9.6.13 May 14, 2013: iCardiac Releases StudyView Module for iClinica 4G Cardiac Safety Software Platform 136
9.7 Research And Development 136
9.7.1 Jun 04, 2013: Immunicum's Intuvax Is Registered As Brand In EU At Office for Harmonization in the Internal Market 136
9.8 Strategy And Business Planning 137
9.8.1 Nov 25, 2013: Bioheart Announces New Clinical Site in Mexico 137
9.8.2 Nov 06, 2013: Welch Allyn Establishes New Regional Headquarters, Operations Center in The Netherlands 138

9.8.3 Nov 04, 2013: Bioheart Announces Agreement With Global Stem Cell Group to Provide Bioheart Therapies and Training 139
9.8.4 Jul 25, 2013: First Injection of Dotarem in US Performed at Cincinnati Children's Hospital Medical Center 139
9.8.5 Jul 02, 2013: Apogenix Strengthens Patent Position for Apocept In Europe And Canada 140
10 Appendix 142
10.1 Research Methodology 143
10.1.1 Coverage 143
10.1.2 Secondary Research 143
10.1.3 Primary Research 144
10.1.4 Market Modeling and Forecasting 145
10.1.5 Company Share Analysis 148
10.1.6 Distribution Share Analysis 149
10.2 Expert Panel 149
10.3 GlobalData Consulting 150
10.4 Contact Us 150
10.5 Disclaimer 150

1.1 List of Tables
Table 1: Cardiovascular Monitoring and Diagnostic Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020 14
Table 2: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 16
Table 3: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 18
Table 4: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 20
Table 5: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2020 22
Table 6: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Historic, 2005-2012 24
Table 7: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Forecast, 2012-2020 26
Table 8: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2011-2012 28
Table 9: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 30
Table 10: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 32
Table 11: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Historic, 2005-2012 34
Table 12: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Forecast, 2012-2020 36
Table 13: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Average Price ($), Historic, 2005-2012 37
Table 14: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Average Price ($), Forecast, 2012-2020 38
Table 15: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 39
Table 16: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 41
Table 17: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 43
Table 18: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 45

Table 19: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Historic, 2005-2012 47
Table 20: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Forecast, 2012-2020 49
Table 21: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Average Price ($), Historic, 2005-2012 50
Table 22: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Average Price ($), Forecast, 2012-2020 51
Table 23: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2011-2012 52
Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2011-2012 54
Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 56
Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 58
Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012 60
Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020 62
Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Historic, 2005-2012 63
Table 30: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Forecast, 2012-2020 64
Table 31: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 65
Table 32: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 67
Table 33: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 72
Table 34 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 145

1.2 List of Figures
Figure 1: Cardiovascular Monitoring and Diagnostic Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020 13
Figure 2: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 15
Figure 3: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 17
Figure 4: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 19
Figure 5: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2020 21
Figure 6: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Historic, 2005-2012 23
Figure 7: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Forecast, 2012-2020 25
Figure 8: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Company Share (%), 2012 27
Figure 9: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 29
Figure 10: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 31
Figure 11: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Historic, 2005-2012 33
Figure 12: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Forecast, 2012-2020 35
Figure 13: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share (%), 2012 40

Figure 14: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 42
Figure 15: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 44
Figure 16: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Historic, 2005-2012 46
Figure 17: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Forecast, 2012-2020 48
Figure 18: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Company Share (%), 2012 53
Figure 19: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 55
Figure 20: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 57
Figure 21: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012 59
Figure 22: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020 61
Figure 23: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share (%), 2012 66
Figure 24: GlobalData Epidemiology-Based Forecasting Model 147
Figure 25: GlobalData Capital Equipment-Based Forecasting Model 148
Figure 26: Primary Interviews by Participant Type (%) 149

Companies Mentioned
GE Healthcare
Philips Healthcare
CareFusion Corporation
Welch Allyn Inc.
OSI Systems, Inc.
Opto Circuits India Limited
Schiller AG
Mortara Instrument, Inc.
Nihon Kohden Corporation
Fukuda Denshi Co., Ltd.

To order this report: North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020
http://www.reportlinker.com/p02133166/North-America-Cardiovascular-Monitoring-and-Diagnostic-Devices-Market-Outlook-to-2020.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Pro AV, Post/Production, Management, Presentors, Dealer/Distributor, Management, Director, Data Management, Business, Marketing, Anim, Business Issues, Presentation, Channel/Distribution, Marketing, Corporate/Company, Training, Canada, USA, India, Inc., Medicine, Insurance, healthcare, medical technologists,

HOT THREADS on DMN Forums
Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!
Windows OS
BKF File Recovery Software • alishaallen398@yahoo.com  
    • Re: BKF File Recovery Software • watson

@ Copyright, 2014 Digital Media Online, All Rights Reserved